FindTrial
Sign In

Usefulness and Tolerability of Postoperative Adjuvant Chemotherapy for Colorectal Cancer in the Elderly

Usefulness and Tolerability of Postoperative Adjuvant Chemotherapy for Colorectal Cancer in the Elderly - Usefulness and Tolerability of Postoperative Adjuvant Chemotherapy for Colorectal Cancer in the Elderly

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000047960
Enrollment
7405
Registered
2022-06-06
Start date
2022-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

None listed

Sponsors

Tani Building 3F, 1-28-6 Kameido, Koto-ku, Tokyo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All colorectal cancer patients enrolled in clinical studies conducted by JFMC in the past (No 7, 15, 33, 35, 37, 38, 41) who received adjuvant chemotherapy will be included. Any type of chemotherapy and duration of administration.

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
Relapse-free survival Overall survival Safety Tolerability Recurrence rate—

Countries

Japan

Contacts

Public ContactYukari/Masaru Kawamura/Mutoh

Japanese Foundation for Multidisciplinary Treatment of Cancer Data Management Section/Statistical Analysis Section

jfmc-dc@jfmc.or.jp0356277594

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026